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Abstract The expression of high affinity neurotrophin receptors (T&A, TrkB, and TrkC) determines the survival response of different populations 
of neurons to specific members of the neurotrophin family, including nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and 
neurotrophin-3 (NT-3). However, the mechanism which controls the expression of neurotrophin receptors during neuronal development is largely 
unknown. Here we show that the treatment of the cultured sympathetic neurons from newborn rat superior cervical ganglia (SCG) with retinoic acid 
(RA), a derivative of vitamin A, suppressed the expression of trkA mRNA and induced the expression of trkB mRNA. Expression of the functional 
TrkB receptor was confirmed by the emergence of trophic dependence of these neurons on BDNF in the absence of NGF. Differential regulation 
of trk mRNAs by RA provides a possible model for the establishment of neurotrophin dependence of peripheral neurons. 
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1. Introdwtion 
The survival, maturation, and function of post-mitotic neu- 
rons are regulated by neurotrophic factors. The neurotrophins, 
the NGF family of neurotrophic factors, were the first identi- 
fied and are a still expanding group of neurotrophic factors 
acting on various types of neurons at different developmental 
stages [1,2]. Recently, the gene family of the receptor tyrosine 
kinase, Trk (now also referred to as TrkA as the receptor for 
NGF, while TrkB and TrkC denote the main receptors for 
BDNF and NT-3, respectively) was identified as a signal- 
transducing as well as ligand-specifying component of the high 
affinity neurotrophin receptor [3-6]. Genes for the Trk family 
receptors encode both full-length, 130-145 kDa proteins and 
truncated variants lacking an intracellular tyrosine kinase do- 
main. Although the roles of truncated forms of Trk receptors 
expressed in both neuronal and non-neuronal cells remain to 
be clarified, full-length Trk receptors are expressed only in 
neuronal cells and mediate the biological action of neurotro- 
phins on these cells. 
Analysis of the regulation of trk mRNA expression should 
allow us to assay environmental signals which may induce or 
alter neurotrophin responsiveness of various types of neurons 
during neural development [3,7]. Some reports describe neuro- 
trophin-responsive cell lines as model systems for the regulation 
of neurotrophin receptor expression [8-lo]. Primary cultures of 
adrenergic sympathetic neurons from superior cervical ganglia 
(SCG) provide another model system to study neuronal differ- 
entiation of the peripheral nervous system of neural crest ori- 
gin. Recently it has become apparent that neural crest-derived 
cells, such as sensory and sympathetic neurons, undergo a de- 
velopmental switch in trophic factor dependence from neuro- 
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trophins (BDNF, NT-3), produced by autocrine and/or parac- 
rine mechanism, to neurotrophins (NGF, BDNF), produced by 
target tissue [l 11. Retinoic acid (RA), which has been shown to 
induce neurotrophin dependence of immature sympathetic neu- 
rons and neural crest cells [12,13], may be involved in such a 
developmental switch. In the present study, we examined 
whether RA affects the expression of neurotrophin receptors 
and neurotrophin responsiveness of cultured sympathetic neu- 
rons. The results demonstrate that RA induces BDNF respon- 
siveness of SCG neurons by the differential alteration of trk 
mRNA expression. 
2. Materials and methods 
2.1. Primary culture of SCG neurons 
SCG were dissected from 2-day-old Wistar rats, and were sequen- 
tially digested with collagenase (Sigma; 3 mglml) for 30 min and trypsin 
(Difco; 2 mg/ml) for 30 min at 37°C. After centrifugal washing, cells 
were dissociated by trituration. A single cell suspension was plated onto 
35 mm culture dishes precoated with poly-D-lysine (Sigma; 0.1 mg/ml) 
and laminin (Collaborative Research; 1 &cm*) to give a density of 
approximately 5 ganglia per dish. On the day following seeding, the 
culture medium was replenished and cytosine-B-o-arabinofuranoside 
(Sigma; 10 PM) was added for 3 days to prevent proliferation of non- 
neuronal cells. SCG neurons were cultured in the absence or presence 
of all-tram retinoic acid (RA; Sigma; 0.1 PM) in the basal culture 
medium supplemented with NGF @omega; 40 &ml) for 6 days. The 
basal culture medium consisted of Ham’s F-12 medium (Sigma) con- 
taining BSA (0.1 mg/ml), streptomycin (0.1 mg/ml), penicillin (50 U/ml) 
and N2 supplement [14]. 
2.2. RNA preparation and Northern blot analysis 
Total RNA was prepared from the cells according to the method of 
Chomczynski and Sacchi [15] with slight modifications as described 
previously [16]. For Northern blot analysis, total RNA (7 pg for trkA 
and trkB, 1.4 pg for ~75) was subjected to electrophoresis through a 
1.5% agarose gel and transferred to a nylon membrane (Hybond-N; 
Amersham). The membrane was hybridized with ‘*P-labeled cRNA 
probe at 65°C in 50% formamide. A trkA cRNA probe corresponded 
to 618 bp of the extracellular domain of rat trkA cDNA [4], and a trkB 
cRNA probe was a mixture of 492 bp of the extracellular domain and 
510 bp of the intracellular tyrosine kinase domain of rat trkB cDNA 
[5]. The ~75 cRNA probe corresponded to 554 bp of the extracellular 
domain [17J The membrane initially hybridized with the trkA probe 
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was strip-washed and rehybridiied with a 420 bp mouse /3-actin cRNA 
probe to evaluate the level of &rctin expression as an internal control 
(cf. Fig. 1A). 
2.3. RT-PCR 
Aliquots (0.15pg) of the total RNA samples were treated with DNase 
I (Takara; 0.07 U&l) at 37°C for 15 min, and single-strand cDNA was 
synthesized with 0.5 PM random hexamer and AMV-XL reverse tran- 
scriptase (Life Sciences Inc.; 0.25 U&l) at 42“C for 45 min. PCR was 
performed in a total volume of 50 ~1 containing cDNA, 50 mM KCl, 
10 mM Tris-HCl (PH 9.0), 1.5 mM MgCl,, 0.2 mM dNTPs, 0.1% Triton 
X-100,0.5 PM each 5’ and 3’ primers, 50 &i/ml [a-32P]dCTP and 0.02 
U&l Tag polymerase (Promega). Samples were subjected to 30-36 
cycles of PCR according to the following scheme; 94°C for 1 min, 55°C 
for 1 mitt, 72°C for 2 min. The PCR products were electrophoresed on 
a polyacrylamide gel and the radioactivity incorporated into cDNA 
fragments was quantified with a Bio-Image Analyzer (Fuji). The ampli- 
fied regions of the cDNA were as follows; trkA, 291-908[4]; trkB(e), 
116-607; trkB(k), 1422-1931[5]; t&C(e), 186-739; r&C(k), 1459- 
1943[6]; ~75, 16&713 [17,18]. Numbers denote nucleotide positions in 
the corresponding cDNA in the original references. Primer pairs for 
trkA, trkB(e) and r&C(e) and ~75 were located in the extracellular 
domain, while primer pairs for zrkB(k) and t&C(k) were located in the 
intracellular tyrosine kinase domain. 
2.4. Bioassay of neurotrophin activity 
Cultures were established as described above. Dissociated SCG neu- 
rons were seeded into each 16mm well of a 12-well plate at a density 
of 1.5 ganglia per well. During the period of the pretreatment, the 4 days 
following seeding, SCG neurons were cultured in de basal culture 
medium supplemented with NGF (40 &ml) alone or NGF + RA 
(0.1 PM). The medium then was replenished and different neurotro- 
phins (40 &ml) and RA (0.1 FM) were added as indicated in Figs. 2 
and 3. Wells devoid of added NGF received anti-mouse-NGF (Wake 
Chemicals, 5 ,&nl) to neutralize residual NGF. At appropriate stages 
of culture, the number of surviving neurons (cells with round and 
phase-bright soma and neurites) within a 2 x 3 mm rectangle in each 
well was counted. Human recombinant BDNF and human recombi- 
nant NT-3 were provided by Regeneron Pharmaceuticals Inc. 
3. Results and discussion 
3.1, Effects of RA on the expression of neurotrophin receptors 
in cultured SCG neurons 
Dissociated sympathetic neurons require NGF but not 
BDNF for their survival in culture [19]. We also confirmed that 
in the presence of 40 rig/ml NGF, 83% of the plated SCG 
neurons dissociated from neonatal rat SCG had survived after 
4 days in culture. In the presence of NGF, SCG neurons formed 
extensive neurite networks and could be cultured for more than 
3 weeks without a significant decrease in cell number (see Fig. 
3a). Accordingly the neonatal SCG neurons express high level 
of TrkA as well as ~75, a low affiity common neurotrophin 
receptor which lacks an identifiable signal-transducing domain. 
In the absence of NGF or in the presence of BDNF alone, no 
neurons survived after 4 days in culture (also see Fig. 3g and 
c). In contrast, in the presence of 40 rig/ml NT-3, 19% of the 
plated neurons had survived after 4 days in culture (see also Fig. 
3e), in agreement with reports that neonatal SCG neurons ex- 
press a low level of NT-3 receptor (TrkC) compared to the high 
level of NGF receptor (T&A) [20,21]. 
Total cellular RNA from neonatal SCG neurons cultured in 
the absence or presence of RA for 6 days was evaluated for 
changes in the levels of mRNAs for trks and ~75 by either 
Northern blot analysis or reverse transcription-polymerase 
chain reaction (RT-PCR). As shown in Fig. lA, Northern blot 
analysis with total RNA from the cultured SCG neurons indi- 
cated that the RA treatment induced a remarkable increase in 
trkB 
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Fig. 1, RA differentially regulates the expression of neurotrophin recep- 
tor mRNAs in cultured svmuathetic neurons. SCG neurons were cul- 
tured in the absence or preset&e ofO.l PM RA, in basal culture medium 
supplemented with NGF @omega; 40 ng/ml) for 6 days. Then, total 
RNA was extracted from SCG neurons and subjected to (A) Northern 
blot analysis or (B) quantitative RT-PCR analysis for the evaluation 
of trkA, trkB, t&C and ~75 expressions. *P < 0.01; **P < 0.001; RA 
vs. control. 
the level of 7.8 kb trkB mRNA species, which was almost 
undetectable in the untreated neurons. In the brain, the exis- 
tence of multiple species of trkB mRNA encoding both the 
full-length TrkB receptor (4.8-9.0 kb), with intracellular tyro- 
sine kinase catalytic domain, and the truncated form of TrkB 
(0.7-7.5 kb), lacking the tyrosine kinase domain, has been re- 
ported [5]. At present we cannot attribute the 7.8 kb trkB 
mRNA induced by RA in SCG neurons to a particular trkB 
mRNA species reported in the brain. To quantify the levels of 
trkB mRNAs derived from the extracellular domain and the 
intracellular tyrosine kinase domain, we designed two pairs of 
PCR primers corresponding to these two regions. RT-PCR 
experiments using these primers indicated low levels of expres- 
sion of both the extracellular domain and the intracellular tyro- 
sine kinase domain in the SCG neurons without the RA treat- 
ment. The RA treatment for 6 days resulted in increases in the 
expression of both the extracellular domain and the intracellu- 
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Fig. 2. RA pretreatment induces BDNF-dependent survival of cultured 
sympathetic neurons in the absence of NGF. SCG neurons were pre- 
treated with NGF alone or NGF + 0.1 ,uM RA for 4 days. Then, the 
medium was replenished and the SCG neurons were further cultured 
in the presence of indicated combinations of RA and neurotrophins. At 
the end of pretreatment and at 3 and 7 days after the pretreatment, the 
number of surviving neurons within rectangles in each well was counted 
(see section 2). Results were indicated as percentages of the number of 
neurons surviving in the same rectangle at the end of the pretreatment. 
Each bar represents the mean + S.D. from eight rectangles from two 
identical cultures. 
lar tyrosine kinase domain by 6- and 45fold, respectively 
(Fig. 1B. trkB(e), trkB(k)). These results strongly suggest hat 
the RA treatment induced the expression of the full-length 
TrkB receptor with tyrosine kinase domain in the SCG neu- 
rons, although a concomitant increase in the expression of the 
truncated form of the t&B receptor can not be excluded. 
In contrast, the RA treatment of the SCG neurons for 6 days 
led to suppression of the 2.8 kb trkA mRNA to 60% of the 
untreated level in Northern blot analysis while the expression 
of /I-actin mRNA was unchanged (Fig. 1A). The RT-PCR 
experiment using a primer pair located in the extracellular do- 
main of trkA cDNA also indicated that the RA treatment 
resulted in the suppression of the trkA mRNA to 50% (Fig. lB, 
trkA). It is already known that neonatal rat SCG neurons 
express a high level of trkA mRNA with the size of 3.2 kb[21]. 
To our knowledge, the existence of any truncated form lacking 
the tyrosine kinase domain has not been reported for trkA 
mRNA. Therefore, our results strongly suggest hat the RA 
treatment suppresses the expression of the functional TrkA 
receptor and leads to a reduction in the sensitivity of the SCG 
neurons to the NGF required for their survival. 
Our RT-PCR experiment, however, detected certain levels of 
expression of both the extracellular domain and the intracellu- 
lar tyrosine kinase domain of trkC mRNA in the SCG neurons 
without the RA treatment, corresponding to the NT-3 depend- 
ence of these neurons (Fig. 1B. trkC(e) and trkC(k), also see 
Figs. 2 and 3). The RA treatment selectively increased the 
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expression of the extracellular domain of the t&C mRNA by 
4-fold, but not that of intracellular tyrosine kinase domain 
(Fig. lB, trkC(e), trkC(k)). In addition, we found that the RA 
treatment increased the expression of p75 mRNA in the SCG 
neurons (3.5- and 2-fold as measured by Northern blot analysis 
and RT-PCR, respectively). 
3.2. Induction of BDNF-dependent survival of SCG neurons 
by RA 
We examined how the differential regulation of neurotrophin 
receptor expression by RA leads to the alteration of the speci- 
ficity of neurotrophin responsiveness of the SCG neurons 
(Fig. 2). SCG neurons were cultured in the presence of NGF 
or NGF + 0.1 PM RA for 4 days from the time of plating (the 
pretreatment period). The culture medium was then replen- 
ished and SCG neurons received different neurotrophins and 
anti-NGF antibody to neutralize the residual activity of NGF. 
After the pretreatment with RA + NGF, 37 and 23% of original 
number of SCG neurons found live at the end of the pretreat- 
ment survived at 3 and 7 days, respectively, in subsequent 
culture with BDNF and RA. However, after the pretreatment 
with NGF alone, no significant survival of SCG neurons was 
observed in subsequent culture with BDNF (Fig. 3~). Further- 
more, the RA-pretreatment itself had no survival promoting 
effect on SCG neurons in subsequent culture in the absence of 
neurotrophins. As shown in Fig. 3d, SCG neurons surviving in 
the presence of BDNF after the RA pretreatment had a large, 
round cell soma and extended a fine network of neurites; but 
the neurite network was somewhat sparser than the that of 
SCG neurons cultured in the presence of NGF, corresponding 
to the decreased cell number in the presence of RA. These 
results clearly indicate that the survival responsiveness to 
BDNF was induced in a subpopulation of postnatal SCG neu- 
rons during the pretreatment period by RA, corresponding to 
the induction of trkB mRNA containing the tyrosine kinase 
domain. We do not know exactly how long it takes for RA to 
induce responsiveness to BDNF in the SCG neurons. We ob- 
served that the 3-day pretreatment with RA resulted in a sur- 
vival response of SCG neurons to BDNF with a similar per- 
centage of surviving neurons to that in the 4-day RA pretreat- 
ment. Therefore, we reasoned that 3 days is enough for RA to 
induce the expression of the functional receptor for BDNF. 
Furthermore, it is suggested that the maximum size of a sub- 
population of SCG neurons which expresses the functional 
BDNF receptor at levels above threshold to give a survival 
response to BDNF is one-third of the original population. 
Although, in the culture medium containing NGF without 
RA, SCG neurons survived for more than 3 weeks without a 
significant decrease in cell number, the pretreatment of SCG 
neurons with RA induced a gradual decrease in cell number 
even in the presence of NGF (Fig. 2, bar RA + NGF). Since 
the RA pretreatment suppressed the expression of the trkA 
mRNA, it is reasonable to conclude that RA suppresses the 
NGF responsiveness of the SCG neurons. Additionally, SCG 
neurons cultured in the presence of RA also formed an exten- 
Fig. 3. Phase-contrast photomicrographs of sympathetic neurons in culture with different neurotrophins and RA. Cultures of SCG neurons were 
established as described in section 2. After the pretreatment with NGF alone (a, c, e, g) or NGF + 0.1 PM RA (b, d, f, h) for 4 days, the medium 
was replenished and the SCG neurons were further cultured in the presence of the following combinations of RA and neurotrophins for 7 days before 
photographs were taken. (a) NGF; (b) RA + NGF; (c) BDNF; (d) RA + BDNF; (e) NT-3; (f), RA + NT-3; (g) none; (h) RA. Bar = 100 pm. 
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sive network of neurites, although these SCG neurons tended 
to extend thicker bundles of neurites compared with the SCG 
neurons cultured in the absence of RA (Fig. 3b). 
In contrast, the inclusion of RA during the pretreatment 
period did not significantly change the number of surviving 
neurons in culture medium containing NT-3. However, subse- 
quent to the 4-day pretreatment period, percentages of SCG 
neurons that survived in the presence of NT-3 for 3 days (pre- 
treatment with NGF, 7.2%; pretreatment with NGF + RA, 
8.0%) were much smaller than those of SCG neurons surviv- 
ing at 4 days with NT-3 from the time of plating (NT-3, 
19%; NT-3 + RA, 14%). This result coincides with the pro- 
gressive loss of the t&C receptor in SCG neurons during the 
late embryonic and neonatal period [20,21], which seems to be 
a process independent of the action of RA. 
Differential regulation of the expression of trk neurotrophin 
receptors by RA has profound implications on the establish- 
ment of neurotrophin responsiveness of various types of neu- 
rons during development. Induction of trkB mRNA by RA is 
also reported in some human neuroblastoma cell lines [9]. How- 
ever, regulation of trkA mRNA by RA is not known in these 
cell lines. Recently, it has become apparent that sympathetic 
neurons undergo a developmental switch in trophic factor de- 
pendence [111. At the embryonic stage, NT-3 promotes survival 
of sympathetic neuroblasts via activation of TrkC [20,21]. As 
sympathetic neurons start innervating their targets during late 
embryonic and neonatal stages, the expression of TrkC is re- 
placed by onset of the expression of TrkA. Hence, they become 
dependent on NGF produced by the target tissue [20,21]. We 
do not know whether RA affects TrkC expression and NT-3 
responsiveness of sympathetic neurons during embryonic de- 
velopment, rather, we would like to include BDNFfIrkB as an 
another neurotrophin/receptor system which supports survival 
and maturation of sympathetic neurons at their early develop- 
mental stage. RA has been shown to promote the survival and 
proliferation of neurogenic precursors in cultured neural crest 
cell populations [ 131. Subpopulations of neural crest-derived 
cells in dorsal root ganglia and sympathetic ganglia in the chick 
have been found to express a certain type of nuclear RA rccep- 
tor [22]. These observations suggest hat RA acts on the early 
stage of the differentiation of neural crest-derived neurons such 
as sensory and sympathetic neurons. Recently, it was reported 
that RA induces high affinity NGF receptor and NGF depend- 
ence in chick sympathetic neuroblasts [12]. However, in our 
cultured rat sympathetic neuron system, RA suppressed the 
expression of trkA mRNA. This finding coincides with the 
observation that RA did not induce trkA mRNA in MAH cells, 
immortalized rat sympathoadrenal progenitor cells, where de- 
polarization is a major T&A-inducing signal [8]. Rather, induc- 
tion of high affiity NGF receptor and NGF dependence in the 
chick system might refIect he increase of ~75 expression by RA 
t101. 
In a separate study, we showed that umuyelmated Schwann 
cells in a premature state are capable of synthesizing and secret- 
ing BDNF [23]. Interestingly, expressions of BDNF and NGF 
mRNA are differentially regulated in Schwann cells. Further- 
more, it has been shown that ciliary neurotrophic factor 
(CNTF) induces responsiveness of neonatal rat SCG neurons 
to trophic factor(s) (which could be BDNF) produced by 
Schwann cells [24]. CNTF resembles RA in its action on SCG 
neurons. Thus, both CNTF and RA induce cholinergic differ- 
entiation in several cell types, including neonatal rat SCG neu- 
rons [16,25]. Therefore, it is highly plausible that during early 
stages of development of SCG neurons, RA and other factors 
induce TrkB expression and responsiveness to BDNF pro- 
duced by ganglionic non-neuronal cells such as Schwann cells. 
The trophic functions of the NT-3flrkC and BDNFflrkB sys- 
tems in sympathetic neurons at the embryonic stage could be 
complementary or compensate ach other, since the disruption 
of any single gene among the four neurotrophinlreceptor genes 
does not lead to complete loss of sympathetic ganglia [26-311. 
To further confhm the role of RA in the development of sym- 
pathetic neurons it is necessary to follow the developmental 
changes of the supply of RA within or in the periphery of the 
sympathetic ganglia and the expression of the relevant retinoid 
receptors. It is also intriguing to examine the effects of RA on 
neurotrophin responsiveness in other systems, such as sensory 
and spinal motor neurons, where a neurotrophic function of 
RA has been suggested [32,33]. In conclusion this is the first 
report that a sympathetic neuron can become dependent on 
BDNF by the RA-induced differential regulation of neurotro- 
phin receptors, which would serve as a model system for the 
establishment of neurotrophin responsiveness. 
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